Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 4/2001

01-04-2001

Effects of Polaprezinc on Lipid Peroxidation, Neutrophil Accumulation, and TNF-α Expression in Rats with Aspirin-Induced Gastric Mucosal Injury

Authors: Yuji Naito, Toshikazu Yoshikawa, Nobuaki Yagi, Kiichi Matsuyama, Norimasa Yoshida, Kohichi Seto, Tomoyuki Yoneta

Published in: Digestive Diseases and Sciences | Issue 4/2001

Login to get access
Metadata
Title
Effects of Polaprezinc on Lipid Peroxidation, Neutrophil Accumulation, and TNF-α Expression in Rats with Aspirin-Induced Gastric Mucosal Injury
Authors
Yuji Naito
Toshikazu Yoshikawa
Nobuaki Yagi
Kiichi Matsuyama
Norimasa Yoshida
Kohichi Seto
Tomoyuki Yoneta
Publication date
01-04-2001
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 4/2001
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1010716804594

Other articles of this Issue 4/2001

Digestive Diseases and Sciences 4/2001 Go to the issue

OriginalPaper

Postprandial Improvement of Gastric Dysrhythmias in Patients with Type II Diabetes

OriginalPaper

CASE REPORT: Spontaneous Gastric Rupture and Hemoperitoneum Due to Gastric Hemangioma

OriginalPaper

CASE REPORT: Porcelain Gallbladder and Cholangiocarcinoma with Anomalous Pancreaticobiliary Union

OriginalPaper

Differential Oxidative Injury in Extrapancreatic Tissues During Experimental Pancreatitis

OriginalPaper

Diagnostic Value of DNA Image Cytometry in Ulcerative Colitis

OriginalPaper

Cholecystokinin (CCK) Secretion in Patients with Severe Short Bowel Syndrome (SSBS)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits